Endovascular management of acute stroke

Journal of Cardiovascular Surgery

Volumn 54, Issue 1, 2013, Pages 101-114

  Simonetti, G ^a   Stefanini, M ^a   Konda, D ^a   Marziali, S ^a   Da Ros, V ^a   Chiaravalloti, A ^a   Pampana, E ^a   Gandini, R ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Endovasular procedures; Stroke; Thrombectomy

Indexed keywords

ALTEPLASE; DESMOTEPLASE;

BLEEDING; BLOOD CLOT LYSIS; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; DECISION MAKING; DIFFUSION WEIGHTED IMAGING; FIBRINOLYSIS; HUMAN; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFUSION WEIGHTED IMAGING; RECANALIZATION; REVASCULARIZATION; REVIEW; SENSITIVITY AND SPECIFICITY; STENT; THROMBECTOMY; ENDOVASCULAR SURGERY; METHODOLOGY;

ENDOVASCULAR PROCEDURES; HUMANS; STROKE; THROMBECTOMY;

MLCS; MLOWN;

EID: 84874446334     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (103)

1. Lloyd-Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statistics 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009;119:e21e181.
2. Quaderni del Ministero della salute n. 14 - Marzo-Aprile 2012 - Criteri di appropriatezza strutturale, tecnologica e clinica nella prevenzione, diagnosi e cura della patologia cerebrovascolare [Internet]. Available at http://www.quadernidellasalute.it/download/download/14-marzo-aprile-2012- quaderno.pdf [cited 2012, Dec 17].
3. Brandt T, von Kummer R, Müller-Küppers M, Hacke W. Thrombolytic therapy of acute basilar artery occlusion. Variables affecting recanalization and outcome. Stroke 1996;27:875-81. (Pubitemid 26142517)
4. Hacke W, Schwab S, Horn M, Spranger M, De Georgia M, von Kummer R. 'Malignant' middle cerebral artery territory infarction: Clinical course and prognostic signs. Arch Neurol 1996;53:309-15. (Pubitemid 26110085)
5. Jansen O, Von Kummer R, Forsting M, Hacke W, Sartor K. Thrombolytic therapy in acute occlusion of the intracranial internal carotid artery bifurcation. Am J Neuroradiol 1995;16:1977-86.
6. Rha JH, Saver JL. The impact of recanalization on ischemic stroke outcome: A meta-analysis. Stroke 2007;38:967-73. (Pubitemid 46568460)
7. Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP et al. Association of outcome with early stroke treatment: Pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004;363:768-74.
8. Bhatia R, Hill MD, Shobha N, Menon B, Bal S, Kochar P et al. Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: Real-world experience and a call for action. Stroke 2010;41:2254-8.
9. Baker WL, Colby JA, Tongbram V, Talati R, Silverman IE, White CM et al. Neurothrombectomy devices for the treatment of acute ischemic stroke: State of the evidence. Ann Intern Med 2011;154:243-52.
10. IMS Study Investigators: Combined intravenous and intra-arterial recanalization for acute ischemic stroke: The interventional management of stroke study. Stroke 2004;35:904-11.
11. IMS II Trial Investigators: The interventional management of stroke (IMS) II study. Stroke 2007;38:2127-35.
12. del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowley HA, Gent M. PROACT: A phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT investigators. Prolyse in acute cerebral thromboembolism. Stroke 1998;29:4-11. (Pubitemid 28046933)
13. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: A randomized controlled trial. Prolyse in acute cerebral thromboembolism. JAMA 1999;282:2003-11.
14. Alberts MJ, Latchaw RE, Selman WR, Shephard T, Hadley MN, Brass LM et al. Recommendations for comprehensive stroke centers: a consensus statement from the Brain Attack Coalition. Stroke 2005;36:1597-616. (Pubitemid 40973803)
15. Leifer D, Bravata DM, Connors JJ 3rd, hinchey JA, Jauch EC, Johnston SC et al. Metrics for measuring quality of care in comprehensive stroke centers: detailed follow-up to Brain Attack Coalition comprehensive stroke center recommendations: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011;42:849-77.
16. Meyers PM, Schumacher HC, Higashida RT, Barnwell SL, Creager MA, Gupta R et al. Indications for the performance of intracranial endovascular neurointerventional procedures: a scientific statement from the American Heart Association Council on Cardiovascular Radiology and Intervention, Stroke Council, Council on Cardiovascular Surgery and Anesthesia, Interdisciplinary Council on Peripheral Vascular Disease, and Interdisciplinary Council on Quality of Care and Outcomes Research. Circulation 2009;119:2235-49.
17. Adams HP Jr, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups. Stroke 2007;38:1655-711. (Pubitemid 46691097)
18. The National Institute of Neurological Disorders and Stroke rtPA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-7.
19. Zaidat OO, Suarez JI, Sunshine JL, Tarr RW, Alexander MJ, Smith TP et al. Thrombolytic therapy of acute ischemic stroke: correlation of angiographic recanalization with clinical outcome. AJNR Am J Neuroradiol 2005;26:880-4. (Pubitemid 43079785)
20. Smith WS, Sung G, Starkman S, Saver JL, Kidwell CS, Gobin YP et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005;36:1432-8. (Pubitemid 40967507)
21. Penumbra Pivotal Stroke Trial Investigators. The penumbra pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 2009;40:2761-68.
22. Yoo AJ, Barak ER, Copen WA, Karmalian S, Gharai LR, Pervez MA et al. Combining acute diffusionweighted imaging and mean transmit time lesion volumes with National Institutes of Health stroke scale score improves the prediction of acute stroke outcome. Stroke 2010;41:1728-35.
23. DeGraba TJ, Hallenbeck JM, Pettigrew KD, Dutka AJ, Kelly BJ. Progression in acute stroke: Value of the initial NIH stroke scale score on patient stratification in future trials. Stroke 1999;30:1208-12. (Pubitemid 29259175)
24. Maas MB, Furie KL, Lev MH, Ay H, Singhal AB, Dreer DM et al. National Institutes of Health stroke scale score is poorly predictive of proximal occlusion in acute cerebral ischemia. Stroke 2009;40:2988-93.
25. Barber PA, Demchuk AM, Zhang J, Buchan AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet 2000;355:1670-4. (Pubitemid 30248478)
26. Gasparotti R, Grassi M, Mardighian D, Frigerio M, Pavia M, Liserre R et al. Perfusion CT in patients with acute ischemic stroke treated with intra-arterial thrombolysis: predictive value of infarct core size on clinical outcome. Am J Neuroradiol 2009; 30:722-7.
27. Lev MH, Segal AZ, Farkas J, Hossain ST, Putman C, Hunter GJ et al. Utility of perfusion-weighted CT imaging in acute middle cerebral artery stroke treated with intraarterial thrombolysis: prediction of final infarct volume and clinical outcome. Stroke 2001;32:2021-8.
28. Yoo AJ, Verduzco LA, Schaefer PW, Hirsch JA, Rabinov JD, Gonzalez RG. MRI-based selection for intra-arterial stroke therapy: value of pretreatment diffusion-weighted imaging lesion volume in selecting patients with acute stroke who will benefit from early recanalization. Stroke 2009;40:2046-54.
29. Mlynash M, Lansberg MG, De Silva DA, Lee J, Christensen S, Straka M et al. Refining the definition of the malignant profile: insights from the DEFUSE-EPITHET pooled data set. Stroke 2011; 42:1270-5.
30. Von Kummer R. Early major ischemic changes on computed tomography should preclude use of tissue plasminogen activator. Stroke 2003;34:820e1.
31. Ebinger M, Christensen S, De Silva DA, Parsons MW, Levi CR, Butcher KS et al. Expediting MRI-based proof-of-concept stroke trials using an earlier imaging end point. Stroke 2009;40:1353-8.
32. Barrett KM, Ding YH, Wagner DP, Kallmes DF, Johnston KC; ASAP investigators: change in diffusion-weighted imaging infarct volume predicts neurologic outcome at 90 days: Results of the acute stroke accurate prediction (ASAP) trial serial imaging substudy. Stroke 2009;40:2422-7.
33. Hakimelahi R, Romero J, Nogueira RG. Final infarct volume is the best predictor of outcome in large vessel occlusion patients treated with IAT. In, Annual Meeting of American Society of Neuroradiology Vancouver, British Columbia, Canada; 2009
34. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS) JAMA 1995;274:1017-25.
35. Fiebach JB, Schellinger PD, Jansen O, Meyer M, Wikde P, Bender J et al. CT and diffusion-weighted MR imaging in randomized order: Diffusion-weighted imaging results in higher accuracy and lower interrater variability in the diagnosis of hyperacute ischemic stroke. Stroke 2002;33:2206-10. (Pubitemid 35014631)
36. Barber PA, Darby DG, Desmond PM, Gerraty RP, Yang Q, Li T et al. Identification of major ischemic change. Diffusion-weighted imaging versus computed tomography. Stroke 1999;30:2059-65. (Pubitemid 29473249)
37. Wardlaw JM, Mielke O: Early signs of brain infarction at CT. Observer reliability and outcome after thrombolytic treatment - Systematic review. Radiology 2005;235:444-453. (Pubitemid 40571081)
38. Camargo EC, Furie KL, Singhal AB, Roccatagliata L, Cunnane ME, Halpern EF et al. Acute brain infarct: Detection and delineation with CT angiographic source images versus nonenhanced CT scans. Radiology 2007;244:541-548. (Pubitemid 47080887)
39. Fiebach J, Jansen O, Schellinger P, Knauth M, Hartmann M, Heiland S et al. Comparison of CT with diff sion-weighted MRI in patients with hyperacute stroke. Neuroradiology 2001;43:628-632. (Pubitemid 32755683)
40. Barber PA, Demchuk AM, Zhang J, Buchan AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. Aspects study group. Alberta stroke programme early CT score. Lancet 2000;355:1670-4. (Pubitemid 30248478)
41. Hill MD, Demchuk AM, Tomsick TA, Palesch YY, Broderick JP. Using the baseline CT scan to select acute stroke patients for IV-IA therapy. Am J Neuroradiol 2006;27:1612-6. (Pubitemid 44413533)
42. Hill MD, Rowley HA, Adler F, Eliasziw M, Furlan A, Higashida RT et al. Selection of acute ischemic stroke patients for intraarterial thrombolysis with pro-urokinase by using aspects. Stroke 2003;34:1925-31. (Pubitemid 36944782)
43. Goyal M, Menon BK, Coutts SB, hill MD, Demchuk AM Penumbra Pivotal Stroke Trial Investigators et al. Effect of baseline CT scan appearance and time to recanalization on clinical outcomes in endovascular thrombectomy of acute ischemic strokes. Stroke 2011; 42:93-7.
44. Mullins ME, Schaefer PW, Sorensen AG, halpern EF, Ay H, He J et al. CT and conventional and diffusion-weighted MR imaging in acute stroke: Study in 691 patients at presentation to the emergency department. Radiology 2002; 224:353-60. (Pubitemid 34809112)
45. González RG, Schaefer PW, Buonanno FS, Schwamm LH, Budzik RF, Rodorf G et al. Diffusion-weightedMR imaging: Diagnostic accuracy in patients imaged within 6 hours of stroke symptom onset. Radiology 1999;210:155-62. (Pubitemid 29004297)
46. Fiebach JB, Schellinger PD, Jansen O, Meyer M, Wilde P, Bender J et al. CT and diffusion-weighted MR imaging in randomized order: Diffusion-weighted imaging results in higher accuracy and lower interrater variability in the diagnosis of hyperacute ischemic stroke. Stroke 2002;33:2206-10. (Pubitemid 35014631)
47. Heiss WD, Sobesky J, Smekal Uv, kracht LW, Lehnardt FG, Thieal A et al. Probability of cortical infarction predicted by flumazenil binding and diffusion-weighted imaging signal intensity: A comparative positron emission tomography/magnetic resonance imaging study in early ischemic stroke. Stroke 2004;35:1892-8.
48. Albers GW, Thijs VN, Wechsler L, kemp S, Schlaug G, Skalabrin E et al. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol 2006;60:508e17.
49. Hacke W, Furlan AJ, Al-Rawi Y, Davalos A, Fiebach JB, Gruber F et al. Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study. Lancet Neurol 2009;8:141e50.
50. Nogueira RG, Liebeskind DS, Gupta R. DWI/PWI and CTPassessment in the triage of wake-up and late presenting strokes undergoing neurointervention: the Dawn Trial. Proceedings of the International Stroke Conference, February 17-20, 2009, San Diego, CA.
51. Schellinger PD, Bryan RN, Caplan LR, Detre JA, Edelman RR, Jaigobin C et al. Evidence-based guideline: The role of diffusion and perfusion MRI for the diagnosis of acute ischemic stroke: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2010;75:177e85
52. Hacke W, Kaste M, Bluhmki E, brozman M, Davalos A, Guidetti D et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359:1317-29.
53. Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S. Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset: the ATLANTIS study: a randomized controlled trial: Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA 1999;282:2019-26.
54. Del Zoppo GJ, Saver JL, Jauch EC, Adams HP Jr, American Heart Association Stroke Council. Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. Stroke 2009;40:2945-8.
55. Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P. Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126(3 Suppl):483Se512S.
56. Wahlgren N, Ahmed N, Davalos A, Ford GA, Grond M, Hacke W et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 2007;369:275e82.
57. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C et al. Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study: a randomized controlled trial: Prolyse in Acute Cerebral Thromboembolism. JAMA 1999;282:2003-11.
58. Ogawa A, Mori E, Minematsu K, Taki W, Takahashi A, Nemoto S et al. Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: the Middle Cerebral Artery Embolism Local Fibrinolytic Intervention Trial (MELT) Japan. Stroke 2007;38:2633-9. (Pubitemid 47493996)
59. Eckert B, Kucinski T, Pfeiffer G, Groden C, Zeumer H. Endovascular therapy of acute vertebrobasilar occlusion: early treatment onset as the most important factor. Cerebrovasc Dis 2002;14:42-50. (Pubitemid 34827763)
60. Riedel CH, Zimmermann P, Jensen-Kondering U, Stingele R, Deuschl G, Jansen O. The importance of size: successful recanalization by intravenous thrombolysis in acute anterior stroke depends on thrombus length. Stroke 2011;42:1775e7.
61. Nogueira RG, Schwamm LH, Hirsch JA. Endovascular approaches to acute stroke, part 1: Drugs, devices, and data. AJNR Am J Neuroradiol 2009;30:649e61.
62. Lee M, Hong KS, Saver JL. Efficacy of intra-arterial fibrinolysis for acute ischemic stroke: meta-analysis of randomized controlled trials. Stroke 2010;41:932e7.
63. The Interventional Management of Stroke (IMS) trials [Internet]. Available at: http://www.strokecenter.org/trials/trialDetail.aspx?tid-747. [cited 2011, Aug 26].
64. Lewandowski CA, Frankel M, Tomsick TA, broderick J, Frey J, Clark W. Combined intravenous and intraarterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke 1999;30:2598e605.
65. Wolfe T, Suarez JI, Tarr RW, Welter E, Landis D, Sunshine JL et al. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke. J Stroke Cerebrovasc Dis 2008;17:121e8.
66. Zaidat OO, Suarez JI, Santillan C, Sunshine JL, Tarr RW, Paras VH et al. Response to intra-arterial and combined intravenous and intra-arterial thrombolytic therapy in patients with distal internal carotid artery occlusion. Stroke 2002;33:1821e6.
67. Han MK, Kim SH, Ko SB, Paik NJ, Kwon OK, Lee YS et al. Combined intravenous and intraarterial revascularization therapy using MRI perfusion/diffusion mismatch selection for acute ischemic stroke at 3-6 h after symptom onset. Neurocrit Care 2008;8:353e9.
68. NINDS statement. Interventional management of stroke III trial [Internet]. Available at http://www.ninds.nih.gov/disorders/ clinicaltrialsINCT00359424.htm [cited 2012, Jun 3].
69. Georgiadis AL, Memon MZ, Shah QA, Vazquez G, Suri MF, Lakshminarayan K et al. Comparison of partial (.6 mg/kg) versus full-dose (.9 mg/kg) intravenous recombinant tissue plasminogen activator followed by endovascular treatment for acute ischemic stroke: a meta-analysis. J Neuroimaging 2011;21:113e20.
70. K A Blackham, P M Meyers, T A Abruzzo, F C Albuquerque, D Fiorella, J Fraser et al. Endovascular therapy of acute ischemic stroke: report of the Standards of Practice Committee of the Society of NeuroInterventional Surgery. J NeuroIntervent Surg 2012;4:87e93.
71. Concentric Medical Web Site [Internet]. Available at: http://www.concentric-medical.com/index.php [cited 2012, Dec 17].
72. Smith WS, Sung G, Saver J, Budzik R, Duckwiler G, Liebeskind DS et al. Mechanical thrombectomy for acute ischemic stroke: Final results of the Multi MERCI trial. Stroke 2008;39:1205-12. (Pubitemid 351440692)
73. Gralla J, Schroth G, Remonda L, Nedeltchev K, Slotboom J, Brekenfeld C. Mechanical thrombectomy for acute ischemic stroke: Thrombus-device interaction, efficiency, and complications in vivo. Stroke 2006;37:3019-24. (Pubitemid 44900825)
74. Gobin YP, Starkman S, Duckwiler GR, Grobelny T, Kidwell CS, Jahan R et al. MERCI 1: A phase 1 study of mechanical embolus removal in cerebral ischemia. Stroke 2004;35:2848-54.
75. Kreusch AS, Psychogios MN, Knauth M. Techniques and Results-Penumbra Aspiration Catheter. Tech Vasc Interventional Rad 2012;15:53-9.
76. Castaño C, Dorado L, Guerrero C, milan M, Gomis M, Perez de la Ossa N et al. Mechanical thrombectomy with the solitaire AB device in large artery occlusions of the anterior circulation: A pilot study. Stroke 2010;41:1836-40.
77. Brekenfeld C, Schroth G, Mordasini P, Fischer U, Mono ML, Weck A et al. Impact of retrievable stents on acute ischemic stroke treatment. Am J Neuroradiol 2011;32:1269-73.
78. Pereira VM, Narata AP, Gonzalez AM, Sztajzel R, Lovblad KO. Use of Stentrievers in Acute Stroke: Tips, Tricks, and Current Results. MD. Tech Vasc Interventional Rad 2012;15:68-77.
79. Klisch J, Eger C, Sychra V, Strasilla C, Basche S, Weber J. Stent assisted coil embolization of posterior circulation aneurysms using Solitaire AB: preliminary experience. Neurosurgery 2009;65:258266; discussion 266;
80. Stampfl S, Hartmann M, Ringleb PA, Haehnel S, Bendszus M, Rohde S. Stent placement for flow restoration in acute ischemic stroke: a singlecenter experience with the Solitaire stent system. AJNR Am J Neuroradiol 2011;32:1245-8.
81. Mocco J, Hanel RA, Sharma J, Hauck EF, Snyder KV, Natarajan SK et al. Use of a vascular reconstruction device to salvage acute ischemic occlusions refractory to traditional endovascular recanalization methods. J Neurosurg. 2010;112:557-62.
82. Levy EI, Mehta R, Gupta R, Hanel RA, Chamczuk AJ, Fiorella D et al. Self-expanding stents for recanalization of acute cerebrovascular occlusions. AJNR Am J Neuroradiol 2007;28:816-22. (Pubitemid 46776054)
83. Codman & Shurtleff website [Internet]. Available at http://www.depuy.com/about-depuy/depuy-divisions/codman-and-shurtleff [cited 2012, Dec 17].
84. Trevo product sheet, Stryker website [Internet]. Available at http://www.stryker.com/stellent/groups/public/documents/web-prod/147777.pdf [cited 2012, Dec 17].
85. Bose A, Henkes H, Alfke K, Reith W, Mayer TE, Berlis A et al. The Penumbra System: A mechanical device for the treatment of acute stroke due to thromboembolism. Am J Neuroradiol 2008;29:1409-13.
86. Huded V, Saraf R, Limaye U. Mechanical device the Penumbra system in the management of acute stroke: Report of five cases. Neurol India2009;57:310-2.
87. Penumbra Pivotal Stroke Trial Investigators: The Penumbra Pivotal Stroke Trial: Safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 2009;40:2761-8.
88. Struffert T, Köhrmann M, Engelhorn T, nowe T, Richter G, Schellinger PD et al. Penumbra stroke system as an "add-on" for the treatment of large vessel occlusive disease following thrombolysis: First results. Eur Radiol 2009;19:2286-93.
89. Grunwald IQ, Walter S, Papanagiotou P, Krick C, Hartman K, Dautermann A et al. Revascularization in acute ischaemic stroke using the penumbra system: The first single center experience. Eur J Neurol 2009;16:1210-6.
90. Kulcsár Z, Bonvin C, Pereira VM, Altrichter S, Yilmaz H, Lovblad KO et al. Penumbra System: A novel mechanical thrombectomy device for large-vessel occlusions in acute stroke. Am J Neuroradiol 2010;31:628-33.
91. Menon BK, Hill MD, Eesa M, Modi J, Bhatia R, Wong J et al. Initial experience with the Penumbra Stroke System for recanalization of large vessel occlusions in acute ischemic stroke. Neuroradiology 2011;53:261-6.
92. Tarr R, Hsu D, Kulcsar Z, Bonvin C, Rufenacht D, Alfe K et al. The POST trial: Initial post-market experience of the Penumbra system: Revascularization of large vessel occlusion in acute ischemic stroke in the United States and Europe. J Neurointerv Surg 2010;2:341-4.
93. Kang DH, Hwang YH, Kim YS, Park J, Kwon O, Junc C. Direct thrombus retrieval using the reperfusion catheter of the penumbra system: Forced-suction thrombectomy in acute ischemic stroke. Am J Neuroradiol 2011;32:283-7.
94. Schellinger PD, Hacke W. Recanalization devices should be restricted to clinical trials: Pro (kind of). Stroke 2010;41:191-3.
95. Smith WS. Safety of mechanical thrombectomy and intravenous tissue plasminogen activator in acute ischemic stroke: Results of the multi Mechanical Embolus Removal in Cerebral Ischemia (MERCI) trial, part I. Am J Neuroradiol 2006;27:1177-82. (Pubitemid 44897621)
96. Devlin TG, Baxter BW, Feintuch TA, Desbiens NA. The MERCI retrieval system for acute stroke: The Southeast regional stroke center experience. Neurocrit Care 2007;6:11-21. (Pubitemid 46424446)
97. Kim D, Jahan R, Starkman S, Abolian A, Kidwell CS, Vinuela F et al. Endovascular mechanical clot retrieval in a broad ischemic stroke cohort. Am J Neuroradiol 2006;27:2048-2.
98. Lee W, Sitoh YY, Lim CC, Lim WE, Hui FK. The MERCI retrieval system for the management of acute ischemic stroke - The NNI Singapore experience. Ann Acad Med Singapore 2009;38:749-55.
99. Saver JL, Jahan R, Levy EL, Jovin TG, Baxter B, Nogueira RG et al. Solitaire fl ow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet 2012;380:1241-9.
100. Nogueira RG, Lutsep HL, Gupta R, jovin TG, Albers GW, Walker GA et al. Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet 2012;380:1231-40.
101. Rhode S, Haehnel S, Herweh C, Pham M, Stampfl S, Ringleb PA et al. Mechanical thrombectomy in acute embolic stroke preliminary results with the revive device. Stroke 2011;42:2954-6.
102. Gandini R, Pampana E, Del Giudice C, Massari F, Spano S, Assako Ondo EP et al. Acute stroke treatment using the Penumbra endovascular mechanical thrombolysis device: a single-centre experience. Radiol Med. 2012;117:1199-214.
103. European launch of Penumbra Separator™ 3D announced at the Working Group in Interventional Neuroradiology (WIN) Seminar. Penumbra Website (www.penumbrainc.com).